Jatinder Lamba

The study could pave the way for a new combination therapeutic strategy in clear cell renal cell carcinoma.

The blog series highlights how an interdisciplinary research collaboration involving Dr. Jatinder Lamba's lab led to the identification of a rare genomic phenomenon underlying CD33-negative AML.

UF Health Cancer Institute researchers have created a novel drug that shows promise for the treatment of aggressive AML.

The yearlong ASH program pairs experienced mentors with pediatric and adult hematology/oncology fellows.

UF Health Cancer Institute experts presented innovative research at the American Society of Hematology 67th Annual Meeting and Exposition in Orlando covering the full spectrum of hematology, from leading-edge cellular therapies to novel diagnostic methods incorporating AI to health communications research. The research, which received multiple achievement awards,…

UF Health researchers developed a digital tool that uses artificial intelligence to accelerate the diagnosis of acute leukemias.

The score could be used to identify patients more likely to have worse outcomes and optimize their treatment.

Kathy and Arthur Petsos have lost many loved ones to cancer and donated in memory of those lost to the disease and to support future discoveries.

UF Health Cancer Center member Piyush Jain, Ph.D., created diagnostics and precise genome-editing tools using CRISPR.

The findings could help develop new treatments to overcome resistance to chemotherapy.